Family summary
Current and historical shortage references are available across related Vasopressin presentations from multiple manufacturers.
- 4 current shortage context pages.
- 2 historical shortage context pages.
- 4 manufacturers represented.
Vasopressin - Drug Shortage Information
Public shortage context is available across 6 visible exact NDC pages for this generic drug family.
This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.
Exact NDC product pages in this shortage family
Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.
Common brands and presentations in this family
These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.
Vasopressin 20 [USP'U] / mL Injection 1 mL - NDC 55150-0370-25Eugia US LLC | 25 Vial, Multi-DoseVasopressin 20 [USP'U] / mL Injection 1 mL (Vasostrict) - NDC 42023-0164-10Par Health USA, LLC | 10 VialVasopressin 20 [USP'U] / mL Injection 1 mL (Vasostrict) - NDC 42023-0164-25Par Health USA, LLC | 25 VialVasopressin 0.4 [USP'U] / mL Injection 100 mL (Vasostrict) - NDC 42023-0219-10Par Health USA, LLC | 10 VialVasopressin 20 [USP'U] / mL Injection 1 mL - NDC 00517-1020-25American Regent, Inc. | 25 Vial, Single-Dose
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.